SCHEMBL378795

SCHEMBL378795

NC(=O)Nc1ccn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3451050 0.83
SCHEMBL4511232 0.81
SCHEMBL1012929 0.81
SCHEMBL19350346 0.79
SCHEMBL3994333 0.79
SCHEMBL4383929 0.79 PKM (0.58)
SCHEMBL21413354 0.75 FFAR2 (0.61)
SCHEMBL4383925 0.75 PKM (0.43)
SCHEMBL2826865 0.75 ALOX15 (0.41)
SCHEMBL2661353 0.75 PKM (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115109049-A Triazine compound containing aryl urea structure and application thereof 江西科技师范大学 2022-09-27 CN claimed
JP-4555547-B2 2010-10-06 JP claimed
JP-2004505977-A 2004-02-26 JP claimed
EP-1320531-A2 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2003-06-25 EP claimed
WO-2002012242-A2 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2002-02-14 WO claimed
CN-115109049-B Triazine compound containing aryl urea structure and application thereof 江西科技师范大学 2023-08-15 CN disclosed
CN-115109049-A Triazine compound containing aryl urea structure and application thereof 江西科技师范大学 2022-09-27 CN disclosed
WO-2022159835-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. (US) 2022-07-28 WO disclosed
US-8202899-B2 Pyrazole urea derivatives used as kinase inhibitors ARRAY BIOPHARMA INC. (US) 2012-06-19 US disclosed
EP-1981851-B1 KINASE INHIBITORS AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC (US) 2012-01-25 EP disclosed
US-8044083-B2 Kinase inhibitors and methods of use thereof ARRAY BIOPHARMA INC. (US) 2011-10-25 US disclosed
US-8039639-B2 Kinase inhibitors and methods of use thereof ARRAY BIOPHARMA INC. (US) 2011-10-18 US disclosed
WO-2007089646-A1 KINASE INHIBITORS AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed
EP-1202734-B1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PFIZER ITALIA SRL (IT) 2007-05-02 EP disclosed
EP-1778686-A2 TRIAZOLOPYRIDINYLSULFANYL DERIVATIVES AS P38 MAP KINASE INHIBITORS Pfizer Limited (GB) 2007-05-02 EP disclosed
CN-1273466-C Quinoline derivatives and quinazoline derivatives having azolyl group KIRIN BREWERY (JP) 2006-09-06 CN disclosed
WO-2006018718-A2 TRIAZOLOPYRIDINYLSULFANYL DERIVATIVES AS P38 MAP KINASE INHIBITORS PFIZER LIMITED (GB) 2006-02-23 WO disclosed
CN-1543459-A Quinoline derivative and quinazoline derivative having azolyl group ������������ʽ���� 2004-11-03 CN disclosed
EP-1320531-A2 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2003-06-25 EP disclosed
WO-2002012242-A2 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2002-02-14 WO disclosed